CHNA

New ETFs

Loncar Debuts ETF to Play China's Biotech, Pharma Companies

Loncar Debuts ETF to Play China’s Biotech, Pharma Companies

By Max ChenAugust 15, 2018

Equity ETFs

Even After a Flop, China ETFs Lead in 2015

By Tom LydonDecember 28, 2015

Equity ETFs

Changes Coming for Some PowerShares ETFs

By Tom LydonDecember 23, 2015

Equity ETFs

China ETFs Stimulated by Stimulus, Infrastructure Spending

By Tom LydonMarch 31, 2015

Equity ETFs

Expect Wider Premiums, Discounts in China A-Shares ETF Ahead

By Tom LydonFebruary 13, 2015

Featured

ETF Performance Report: Q4 & December

By Tom LydonJanuary 1, 2015

Equity ETFs

A-Shares ETFs Could be China Value Plays

By Max ChenJuly 13, 2014

Equity ETFs

China ETFs: Low Inflation Leaves Room for More Stimulus

By Max ChenJuly 9, 2014

Equity ETFs

A-Shares ETFs in Focus After MSCI Rebuffs EM Promotion

By Tom LydonJune 11, 2014

Equity ETFs

Third China A-Shares ETF Debuts in London

By Tom LydonMay 19, 2014

Equity ETFs

A-Shares ETFs Could Benefit From Cross-Market Plans

By Todd ShriberApril 14, 2014

Equity ETFs

Hard to Ignore China A-Shares

By Todd ShriberMarch 20, 2014

Equity ETFs

Move to EM Index Could Benefit A-Shares ETFs

By Todd ShriberMarch 14, 2014

Equity ETFs

Traders Want Cheaper A-Shares Hedge

By Tom LydonJanuary 21, 2014

Equity ETFs

A-Shares ETF Launch a Sign of Increased EM Access

By Tom LydonDecember 30, 2013

Equity ETFs

China ETF Investors Can Mix and Match Flavors

By Max ChenNovember 12, 2013

Equity ETFs

China Paves the Way for More A-Shares ETFs

By Todd ShriberNovember 7, 2013

Equity ETFs

Market Vectors China ETF Seeking Direct A-Shares Exposure

By Todd ShriberNovember 6, 2013

1 2 Next